Nivolumab/Paclitaxel Combo Shows Antitumor Activity in EBV-Related, MSI-H, PD-L1+ Advanced Gastric Cancer
Opdivo combined with paclitaxel showed anti-tumor activity in a phase 1/2 study of gastric cancer patients with a variety of tumor markers,... Read More
Epstein-Barr virus rewires host epigenomes to drive stomach cancer
Epstein-Barr virus is known to raise the risk of gastric cancer. A recent study explains how the virus “rewires” the epigenome to... Read More
Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer
Published in the Future Science Group, new research projects molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer.
Outlooks on Epstein-Barr virus associated gastric cancer
New research finds Epstein-Barr virus associated gastric cancer (EBVaGC) associated gastric cancer, which comprises approximately 10% of gastric cancer, is a promising biomarker.... Read More
